Breaking News Instant updates and real-time market news.

FB

Facebook

$217.50

2.83 (1.32%)

17:48
07/25/18
07/25
17:48
07/25/18
17:48

Facebook sinks 23% after guiding for lower revenue growth in Q3, Q4

  • 25

    Jul

FB Facebook
$217.50

2.83 (1.32%)

07/25/18
BMOC
07/25/18
NO CHANGE
Target $210
BMOC
Market Perform
Facebook price target raised to $210 from $170 at BMO Capital
BMO Capital analyst Daniel Salmon raised his price target on Facebook to $210 after his "deep dive" into the company's main platform and Instagram advertising revenue and format, estimating a $52.8B 2018 advertising revenue generation from the two. The analyst also forecasts a 3-year annualized growth for Facebook at 23% and Instagram at 80% as part of his analysis, driven by the increasing adoption of video ad format in advertising placement. Salmon keeps his Market Perform rating on Facebook, citing "growing costs necessary for content to drive TV budgets to the platform, R&D spending on tools to both manage user data and monitor content, a lack of visibility into monetization at Messenger/WhatsApp, and the emergence of Amazon's (AMZN) advertising business."
07/23/18
JPMS
07/23/18
NO CHANGE
Target $242
JPMS
Overweight
JPMorgan positive on Facebook into Wednesday's earnings report
JPMorgan analyst Doug Anmuth is positive heading into Facebook's Q2 earnings report on July 25. He believes that both user engagement and monetization have "remained strong," despite data security concerns and Europe's General Data Protection Regulation. The analyst's industry checks suggest Facebook continues to see strong demand from a large and growing advertiser base and that return on investment "remains very compelling." Anmuth keeps an Overweight rating on the shares with a $242 price target.
07/20/18
MKMP
07/20/18
NO CHANGE
Target $255
MKMP
Buy
Facebook expected Q2 expense ramp may be too aggressive, says MKM Partners
MKM Partners analyst Rob Sanderson is keeping his Buy rating and $255 price target on Facebook (FB) ahead of its results next week, saying he expects revenue upside and believes that the anticipated ramp in expenses implied in the consensus for earnings may be too aggressive. The analyst also cites greater visibility on monetization and opportunities in WhatsApp and Messenger justifying a higher multiple, which he sees at a full 3-point discount relative to Google (GOOGL) in spite of Facebook's much higher rate of growth.
07/20/18
STFL
07/20/18
NO CHANGE
Target $242
STFL
Buy
Facebook price target raised to $242 ahead of earnings at Stifel
Stifel analyst Scott Devitt is predicting "modest" revenue growth deceleration to 45% growth year-over-year in Q2 from Facebook when it reports next Wednesday, July 25. Across his coverage, he is shifting his view to incrementally favor mega cap U.S. digital advertising over e-commerce outside of China in the near-term as digital advertising growth momentum continues and he sees the potential for multiple expansion. Devitt keeps a Buy rating on Facebook and raised his price target on the stock to $242 from $202.

TODAY'S FREE FLY STORIES

NVS

Novartis

$89.12

-0.2 (-0.22%)

07:18
07/17/19
07/17
07:18
07/17/19
07:18
Conference/Events
Novartis management to meet with Wolfe Research »

Meetings to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 22

    Jul

  • 23

    Jul

  • 25

    Sep

SCHW

Charles Schwab

$41.62

1.34 (3.33%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Recommendations
Charles Schwab analyst commentary  »

Charles Schwab net…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Jul

  • 27

    Oct

IAC

IAC

$231.54

-2.55 (-1.09%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Hot Stocks
IAC to invest $250M in Turo car sharing marketplace »

IAC has agreed to invest…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TWOU

2U

$38.60

-0.34 (-0.87%)

07:17
07/17/19
07/17
07:17
07/17/19
07:17
Initiation
2U initiated  »

KeyBanc bullish on 2U,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ALEC

Alector

$19.06

0.06 (0.32%)

07:15
07/17/19
07/17
07:15
07/17/19
07:15
Conference/Events
Alector management to meet with Morgan Stanley »

Meeting to be held in New…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    Jul

  • 09

    Sep

VEGPF

Vectura Group

$0.00

(0.00%)

07:14
07/17/19
07/17
07:14
07/17/19
07:14
Hot Stocks
Vectura Group continues to seek partner for VR647 Phase III development »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

NUS

Nu Skin

$45.50

1.44 (3.27%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Downgrade
Nu Skin rating change  »

Jefferies downgrades Nu…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Aug

VEGPF

Vectura Group

$0.00

(0.00%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Hot Stocks
Vectura Group board approves capital return of approx. GBP50M »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

, GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

07:13
07/17/19
07/17
07:13
07/17/19
07:13
Recommendations
Alphabet, Alphabet Class A, Facebook, Twitter analyst commentary  »

KeyBanc expects…

GOOG

Alphabet

$1,152.97

2.58 (0.22%)

GOOGL

Alphabet Class A

$1,152.86

2.4 (0.21%)

FB

Facebook

$203.87

-0.06 (-0.03%)

TWTR

Twitter

$38.00

-0.68 (-1.76%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 24

    Jul

  • 25

    Jul

  • 25

    Jul

  • 26

    Jul

  • 30

    Jul

  • 08

    Aug

  • 27

    Oct

CSII

Cardiovascular Systems

$44.00

-1.9 (-4.14%)

07:12
07/17/19
07/17
07:12
07/17/19
07:12
Conference/Events
Cardiovascular Systems management to meet with Lake Street »

Meeting to be held in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 06

    Aug

  • 09

    Sep

  • 12

    Sep

VEGPF

Vectura Group

$0.00

(0.00%)

07:11
07/17/19
07/17
07:11
07/17/19
07:11
Hot Stocks
Vectura Group confirms R&D investment priorities »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$45.30

-1.4 (-3.00%)

07:10
07/17/19
07/17
07:10
07/17/19
07:10
Recommendations
Wells Fargo analyst commentary  »

Wells Fargo price target…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 12

    Oct

VMW

VMware

$172.25

0.03 (0.02%)

07:09
07/17/19
07/17
07:09
07/17/19
07:09
Recommendations
VMware analyst commentary  »

VMware estimates likely…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

SMMT

Summit Therapeutics

$1.35

-0.06 (-4.26%)

07:09
07/17/19
07/17
07:09
07/17/19
07:09
Hot Stocks
Summit presents preclinical data on SMT-571 at STI & HIV World Congress »

Summit Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GHSI

Guardion Health Sciences

$0.97

-0.03 (-3.02%)

07:07
07/17/19
07/17
07:07
07/17/19
07:07
Hot Stocks
Guardion Health Sciences receives patent for MapcatSF in Hong Kong »

Guardion Health Sciences…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DPZ

Domino's Pizza

$246.55

-23.42 (-8.68%)

07:06
07/17/19
07/17
07:06
07/17/19
07:06
Recommendations
Domino's Pizza analyst commentary  »

Domino's Pizza…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 13

    Nov

PSTI

Pluristem

$0.57

0.0319 (5.87%)

07:05
07/17/19
07/17
07:05
07/17/19
07:05
Hot Stocks
Pluristem, U.S. DoD to announce data from studies testing PLX-R18 »

Pluristem Therapeutics…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

GS

Goldman Sachs

$215.57

4.02 (1.90%)

, MS

Morgan Stanley

$44.41

-0.01 (-0.02%)

07:05
07/17/19
07/17
07:05
07/17/19
07:05
Recommendations
Goldman Sachs, Morgan Stanley analyst commentary  »

Goldman Sachs price…

GS

Goldman Sachs

$215.57

4.02 (1.90%)

MS

Morgan Stanley

$44.41

-0.01 (-0.02%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Jul

  • 15

    Oct

ACIU

AC Immune

$5.62

0.1 (1.81%)

, LLY

Eli Lilly

$108.81

0.36 (0.33%)

07:04
07/17/19
07/17
07:04
07/17/19
07:04
Hot Stocks
AC Immune initiates Phase 1 study of ACI-3024 »

AC Immune SA (ACIU)…

ACIU

AC Immune

$5.62

0.1 (1.81%)

LLY

Eli Lilly

$108.81

0.36 (0.33%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 30

    Jul

  • 09

    Sep

  • 16

    Sep

  • 02

    Oct

ANIX

Anixa Biosciences

$4.14

-0.01 (-0.24%)

07:03
07/17/19
07/17
07:03
07/17/19
07:03
Hot Stocks
Anixa Biosciences partnering with Cleveland Clinic for breast cancer vaccine »

Anixa Biosciences has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BRKR

Bruker

$49.61

-0.02 (-0.04%)

07:03
07/17/19
07/17
07:03
07/17/19
07:03
Hot Stocks
Bruker comments on block trade transaction »

Bruker has been advised…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Sep

  • 17

    Jul

07:02
07/17/19
07/17
07:02
07/17/19
07:02
General news
MBA Mortgage Applications Composite Index data reported »

Week of 7/12 MBA Mortgage…

NCNA

NuCana

$9.80

-0.05 (-0.51%)

07:02
07/17/19
07/17
07:02
07/17/19
07:02
Hot Stocks
NuCana doses first patients in Phase I study of NUC-7738 »

NuCana announced that the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CHOOF

Choom Holdings

$0.00

(0.00%)

07:02
07/17/19
07/17
07:02
07/17/19
07:02
Hot Stocks
Choom Holdings to acquire 19.9% equity interest of Coastal Green »

Choom is pleased to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PNC

PNC Financial

$138.66

-1.52 (-1.08%)

07:01
07/17/19
07/17
07:01
07/17/19
07:01
Hot Stocks
PNC Financial sees FY19 revenue up at higher end of low single digits vs. FY18 »

Sees average loans up…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Jul

  • 17

    Jul

  • 16

    Oct

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.